Molecular and functional changes of pulmonary surfactant in response to hyperoxia
- 20 September 2006
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 41 (11), 1025-1039
- https://doi.org/10.1002/ppul.20443
Abstract
Surfactant comprises phosphatidylcholine (PC) together with anionic phospholipids, neutral lipids, and surfactant proteins SP-A to-D. Its composition is highly specific, with dipalmitoyl-PC, palmitoyl-myristoyl-PC, and palmitoyl-palmitoleoyl-PC as its predominant PC species, but with low polyunsaturated phospholipids. Changes in pulmonary metabolism and function in response to injuries depend on their duration and whether adaptation can occur. We examined in rats prolonged (7 days) versus acute (2 days) exposure to non-lethal oxygen concentrations (85%) with respect to the composition and metabolism of individual lung phospholipid molecular species. Progressive inflammation, structural alteration, and involvement of type II pneumocytes were confirmed by augmented bromodeoxyuridine incorporation, broadening of alveolar septa, and increased granulocyte, macrophage, SP-A, and SP-D concentrations. Surfactant function was impaired after 2 days, but normalized with duration of hyperoxia, which was attributable to inhibition but not to alteration in SP-B/C concentrations. Phospholipid pool sizes and PC synthesis by lung tissue, as assessed by [methyl-3H]-choline incorporation, were unchanged after 2 days, although after 7 days they were elevated 1.7-fold. By contrast, incorporation of labeled PC into tissue pools of surfactant and lung lavage fluid decreased progressively. Moreover, concentrations of arachidonic acid containing phospholipids were augmented at the expense of saturated palmitoyl-myristoyl-PC and dipalmitoyl-PC. We conclude a persisting impairment in the intracellular trafficking and secretion of newly synthesized PC, accompanied by a progressive increase in alveolar arachidonic acid containing phospholipids in spite of recovery of acutely impaired surfactant function and adaptive increase of overall PC synthesis. Pediatr Pulmonol. 2006, 41:1025–1039.Keywords
This publication has 28 references indexed in Scilit:
- Apoptosis in Lung Development and Neonatal Lung InjuryPediatric Research, 2004
- METABOLISM OF SURFACTANT PHOSPHATIDYLCHOLINE MOLECULAR SPECIES IN cftrtm1HGU/tm1HGU MICE COMPARED TO MF-1 MICEExperimental Lung Research, 2001
- Inhibitory effect of porcine surfactant on the respiratory burst oxidase in human neutrophils. Attenuation of p47phox and p67phox membrane translocation as the mechanism.JCI Insight, 1995
- Activated polymorphonuclear leukocytes inhibit phosphatidylcholine synthesis in cultured type II alveolar cellsPediatric Pulmonology, 1991
- Role of bovine pulmonary surfactant-associated proteins in the surface-active property of phospholipid mixturesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Proliferation of lymphocyte subsets in the adult rat: a comparison of different lymphoid organsEuropean Journal of Immunology, 1989
- Monoclonal Antibody to 5-Bromo- and 5-Iododeoxyuridine: A New Reagent for Detection of DNA ReplicationScience, 1982
- In Vivo incorporation of choline‐3H, leucine‐3H and galactose‐3H in alveolar type II pneumocytes in relation to surfactant synthesis. A quantitative radioautographic study in mouse by electron microscopyThe Anatomical Record, 1972
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959